

Cureworth Drugs & Intermediates Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.05 Cr
- Satisfied Charges ₹ 10.84 Cr
- Revenue Growth -41.68%
- Profit Growth -69.03%
- Ebitda -45.71%
- Net Worth 6.23%
- Total Assets -4.88%
About Cureworth Drugs & Intermediates
Cureworth Drugs & Intermediates Private Limited (CDIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 June 2010 and has a history of 14 years and eight months. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹13.05 Cr. The company has closed loans amounting to ₹10.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjana Nishad and Ramchandra Nishad serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232MH2010PTC204157
- Company No.
204157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Cureworth Drugs & Intermediates Private Limited offer?
Cureworth Drugs & Intermediates Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, API Intermediate, Common Disease Medicines, Allopathic Cough Syrup, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Cureworth Drugs & Intermediates?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anjana Nishad ![]() | Director | 15-Jun-2010 | Current |
Ramchandra Nishad ![]() | Director | 14-Jun-2010 | Current |
Financial Performance of Cureworth Drugs & Intermediates.
Cureworth Drugs & Intermediates Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.68% decrease. The company also saw a substantial fall in profitability, with a 69.03% decrease in profit. The company's net worth moved up by a moderate rise of 6.23%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cureworth Drugs & Intermediates?
In 2022, Cureworth Drugs & Intermediates had a public holding of 6.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Anuj Engineers (I) Private Limited
Anjana Nishad and Ramchandra Nishad are mutual person
- Anjani Chem Pharma Private Limited
Ramchandra Nishad is a mutual person
Charges (Loans)
₹130.50 M
₹108.43 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 13.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Mar 2023 | Hdfc Bank Limited | ₹6.45 Cr | Open |
24 Mar 2023 | Hdfc Bank Limited | ₹6.60 Cr | Open |
28 Jun 2021 | Bank Of India | ₹2.50 Cr | Satisfied |
07 Apr 2021 | Bank Of India | ₹2.40 M | Satisfied |
01 Aug 2017 | Bank Of India | ₹8.23 M | Satisfied |
How Many Employees Work at Cureworth Drugs & Intermediates?
Cureworth Drugs & Intermediates has a workforce of 39 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cureworth Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureworth Drugs & Intermediates's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Cureworth Drugs & Intermediates
Recent activity within the organization
- Annual General Meeting
Cureworth Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Cureworth Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 28 Jun 2021 via Charge ID 100459046 with Bank Of India was fully satisfied on 07 Feb 2024.
- Charges
A charge registered on 07 Apr 2021 via Charge ID 100439937 with Bank Of India was fully satisfied on 07 Feb 2024.
- Charges
A charge registered on 01 Aug 2017 via Charge ID 100172239 with Bank Of India was fully satisfied on 07 Feb 2024.
- Charges
A charge registered on 26 Feb 2013 via Charge ID 10420590 with Bank Of India was fully satisfied on 07 Feb 2024.
Frequently asked questions
What is the Incorporation or founding date of Cureworth Drugs & Intermediates Private Limited?
Cureworth Drugs & Intermediates Private Limited was incorporated on 14 Jun 2010.
What is authorized share capital and paid-up capital of Cureworth Drugs & Intermediates Private Limited?
The authorized share capital of Cureworth Drugs & Intermediates Private Limited is ₹ 5.00 M and paid-up capital is ₹ 4.00 M.
Who are the current board members & directors of Cureworth Drugs & Intermediates Private Limited?
Currently 2 directors are associated with Cureworth Drugs & Intermediates Private Limited.
- Anjana Ramchadra Nishad
- Ramchandra Rambrish Nishad
What is the registered address of Cureworth Drugs & Intermediates Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Cureworth Drugs & Intermediates Private Limited is Plot No. G-48 2Nd Floor Anjani Niwas Sector 12, Kharghar India, Panvel, Maharashtra, 410210.
What is the corporate identification number (CIN) and company number of Cureworth Drugs & Intermediates Private Limited?
The corporate identification number (CIN) of Cureworth Drugs & Intermediates Private Limited is U24232MH2010PTC204157 and the company number is 204157 as per Ministry of Corporate Affairs (MCA).
What is the official website of Cureworth Drugs & Intermediates Private Limited?
The Official website of Cureworth Drugs & Intermediates Private Limited is https://www.cureworthdrugs.com
What has been the recent revenue trend for Cureworth Drugs & Intermediates Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Cureworth Drugs & Intermediates Private Limited has fallen by -41.68%.
How many employees does Cureworth Drugs & Intermediates Private Limited currently have?
As Per 2022 financial reports, 39 employees are currently employed by Cureworth Drugs & Intermediates Private Limited.
What change has been observed in the net worth of Cureworth Drugs & Intermediates Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Cureworth Drugs & Intermediates Private Limited has experienced an upsurge of 6.23%.
What are the total open charges for Cureworth Drugs & Intermediates Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Cureworth Drugs & Intermediates Private Limited amount to ₹ 13.05 Cr.
When was the last Balance Sheet of Cureworth Drugs & Intermediates Private Limited filed with the ROC?
The most recent Balance Sheet for Cureworth Drugs & Intermediates Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Ashutosh GokhaleDirector
SS
Swati SahaniDirector